Towards quicker accreditation for generics
A pilot programme initiated by Brussels is looking to set up an international generics regulation committee. The aim is for its members (European Union, Australia, Canada, Taiwan and Switzerland) to share their data on generic drugs in real time so as to accelerate the approval process. The programme could then go on to host organisations from other countries, such as Korea, New Zealand, Russia and Japan.